Enhancing the Proline Effect
J. Am. Chem. Soc., Vol. 120, No. 12, 1998 2719
pNA), 8.46 (d, 1H, J ) 8.44 Hz, NH-Phe), 8.21 (d, 2H, J ) 9.08 Hz,
o-pNA), 8.19 (d, 1H, J ) 9.1 Hz, NH-Val), 7.8 (d, 2H, J ) 9.16 Hz,
m-pNA), 7.19-7.26 (m, 5H, aromatics-Phe), 5.29 (d, 1H, J ) 3.36
Hz, 2-C ΨPro), 4.95 (d, 1H, J ) 3.04 Hz, 2-C ΨPro), 4.61 (d × d,
1H, 6.76 Hz, R-Phe), 4.46 (t, 1H, J ) 5.92 Hz, R-Ser), 4.17 (t, 1H, J
) 7.36 Hz, â-Ser), 3.95 (t, 1H, J ) 7.88 Hz, R-Val), 3.79 (d × d, 1H,
5.6 Hz, 5.12 Hz, â-Ser), 3.31 (s, H20), 3.07 (d × d, 1H, J ) 6.32 Hz,
5.76 Hz, â-Phe), 2.96 (d × d, 1H, J ) 8.6 Hz, 7 Hz, â-Phe), 2.49 (s,
DMSO) 2.3-2.49 (m, 4H, suc), 1.89 (m, 1H, â-Val), 0.86 (d, 3H, 3.16
Hz, γ-Val), 0.85 (d, 3H, 3.24 Hz, γ-Val). ESI-MS 584.2 [M]+. HPLC
single peak tR ) 9.51 min (60-100% B, 40 min, C18).
Conclusion
Isomerization of the imidic bond of peptides containing ΨPro
was studied applying a biological assay and dynamic 1H NMR.
It is shown that ΨPro are accepted by chymotrypsin as Pro
and are isomer specifically hydrolyzed similar to their Pro
containing analogues. The significant differences in transition
state energies and kinetics of cis-trans isomerizations between
Xaa-ΨPro and the Xaa-Pro systems are indicative for the
conformational effects of the substituted five-membered rings.
Moreover, ΨPro prove to be valuable tools for delineating the
impact of hydrophobic substituents near the isomerizing imide
bond on the isomerization barrier. The additional stereocenter
at the 2-C ΨPro position allows for the investigation of both
the (R)- and (S)-isomers which show pronounced differences
in isomerization rates and cis contents. For the first time, it is
shown that LiCl/TFE increases stereoselectively the cis contents
of oxazolidine and thiazolidine imide bonds up to 60% cis.
The preferable adoption of the cis conformation of 2-C
dimethylated ΨPro allows for their use as selective cis-Xaa-
ΨPro bond inducer to chemically introduce constraint into
peptides and proteins and to test the cis-imide bond as a
structural requirement for the bioactive conformation.
Suc-Val-Cys(ΨMe,Mepro)-Phe-pNA (4). To Cys(ΨMe,Mepro)-OH‚HCl
(0.2 g, 1 mmol) in THF (10 mL) was added DIEA (210 mg, 2 mmol)
and Fmoc-Val-F16 (281 mg, 0.83 mmol) to stir for 12 h at room
temperature. After removal of the solvent, the white solid was dissolved
in methanol and passed through a silica column (CHCl3/MeOH/HOAc
) 100/10/1) to give 160 mg of pure Fmoc-Val-Cys(ΨMe,Mepro)-OH,
ESI-MS 483.5 [M + H]+. Activation of the dipeptide at -10 °C with
isobutylchloroformate (54 mg, 1.2 equiv) in DCM (10 mL) using NMM
(43 µL, 1.2 equiv) as a base followed by the addition of Phe-pNA (93
mg, 1.05 equiv) gave Fmoc-Val-Cys(ΨMe,Mepro)-Phe-pNA, which was
deprotected without further workup using DBU (5% in DCM, 10 mL,
10 min). The yellow reaction mixture was evaporated to dryness and
taken up in acetonitrile/water (5 mL, 1:1/v/v) before purifying on a
HPLC preparative (C18) using a gradient of 5-100% within 30 min.
Forty milligrams (9.2%) of NH2-Val-Cys(ΨMe,Mepro)-Phe-pNA was
isolated after lyophilization, ESI-MS 528.5 [M + H]+. Succinic an-
hydride (15 mg, 2 equiv) and NMM (17 µL, 2 equiv) in THF (5 mL)
were added to obtain 24 mg (4.6%) of pure Suc-Val-Cys(ΨMe,Mepro)-
Phe-pNA after purification on HPLC (50%-70%, 30 min, C18). HPLC
analytic: tR ) 11.29 min (60-100% B, 40 min, C18), ESI-MS 628.5
Experimental Section
Materials. All protected amino acides were purchased from Cal-
biochem-Novabiochem AG (La¨ufelfingen, Switzerland). Phe-pNA was
purchased at BACHEM (Bubendorf, Switzerland); reagents and solvents
were purchased from Fluka (Buchs, Switzerland) and used without
further purification. HPLC was performed on Waters equipment using
columns packed with Vydac Nucleosil 300 Å 5 µm C18 particles unless
otherwise stated. Analytical columns (250 × 4.6 mm) were operated
at 1 mL/min and preparative columns (250 × 21 mm) at 18 mL/min,
with UV monitoring at 214 nm. Solvent A is water (purified on a
Milli Q Ion exchange cartridge) containing 0.09% TFA, and solvent B
is acetonitrile HPLC-R (containing 10% water and 0.09% TFA),
purchased from Biosolve, Valkenswaard, Netherlands. Mass spectra
were obtained by electron spray ionization (ESI-MS) on a Finnigan
LC 710. 1H NMR spectra were obtained on a Bruker DPX-400 with
trimethylsilane internal standard for intermediate compounds. Ab-
breviations used were as follows: NMM ) N-methylmorpholine, THF
) tetrahydrofurane, DCM ) dichloromethane, DMSO-d6 ) dimethyl
sulfoxide deuterated, DMF ) dimethylformamide, DBU ) 1,8-
diazabicyclo[5.4.0]undec-7-ene(1,5-5), TFA ) trifluoroacetic acid. For
the syntheses of 1R, 1S, and 3, see ref 10.
Suc-Val-Ser(ΨH,Hpro)-Phe-pNA (5). Fmoc-Val-Ser(ΨH,Hpro)-OH
(0.35 g, 0.8 mmol) was dissolved in DCM (10 mL) followed by the
addition of isobutyl chloroformate (120 µL, 1.05 equiv) and NMM
(78 µL, 1.05 equiv) to give a white suspension which was stirred for
30 min under nitrogen at 10 °C. Phe-pNA (239 mg, 1.05 equiv)
dissolved in DCM (2 mL) was added to give a clear solution which
was stirred for 4 h to give Fmoc-Val-Ser(ΨH,Hpro)-Phe-pNA in 60%
(HPLC). All DCM was evaporated, and the remaining yellow solid
taken up in DMF/morpholine (13 mL of a 5% solution). The solution
was turning to yellow after stirring under nitrogen for 4 h. The DMF
was removed and replaced by with ethyl acetate to precipitate. Cooling
to 4 °C for 12 h completed the recrystallization. Two hundred ten
milligrams (54%) of a white substance was separated by filtration, ESI-
MS 484.5 [M + H]+. Test of ninhydrin proved positive.
1
[M + H]+, H NMR (400 MHz, DMSO-d6, 14 mg/mL, 300 K) 10.68
(s, 1H, NH-pNA), 8.29 (d, 1H, d, NH, J ) 6.64 Hz, Phe), 8.2 (d, 2H,
J ) 8.84 Hz, o-pNA), 7.87 (d, 1H, J ) 6.72 Hz, NH-Val), 7.75 (d,
2H, J ) 8.88 Hz, m-pNA), 7.27-7.16 (m, 5h, aromatics-Phe), 4.98 (d,
1H, J ) 6.2 Hz, R-Cys), 4.68 (d × d, 1H, J ) 4.2 Hz, R-Phe), 4.31 (t,
1H, J ) 6.56 Hz, 6.72 Hz, R-Val), 3.35 (d, 1H, J ) 10 Hz, â-Cys), 3.2
(d, 1H, J ) 12.21 Hz, â-Cys), 3.12 (t, 2H, J ) 6.43 Hz, 5.59 Hz,
â-Phe), 2.5-2.2 (m, 4H, suc), 1.91 (d × d, 1H, J ) 6.6 Hz, â-Val),
1.73 (s, 3H, γ-Val), 1.62 (s, 3H, γ-Val), 1.19 (d, 3H, J ) 6.84 Hz,
2-C-CH3), 0.9 (d, 3H, J ) 6.52 Hz, 2-C-CH3).
Suc-Val-Cys(Ψpmppro)-Phe-pNA (2R and 2S). L-Cys hydrochlo-
ride monohydrate (3 g, 17.1 mmol) and potassium acetate (2.5 g, 18.4
mmol) were dissolved in water (26 mL) before the addition of
p-methoxybenzaldehyde (2.86 g, 21 mmol). The reaction mixture was
allowed to stand at room temperature for 3 h. A heavy white precipitate
developed, which was filtrated and washed several times with cold
ethanol before drying in vacuo to give dry (R)- and (S)-Cys(Ψpmppro)-
OH as a diastereomeric mixture. The above synthesized thiazolidine
derivative (0.5 g, 2.09 mmol), NMM (212 mg, 2 equiv) in THF (30
mL), and Fmoc-Val-F (710 mg, 2.1 mmol) were stirred at room
temperature to give Fmoc-Val-Cys(Ψpmppro)-OH with 90% yield
(HPLC). After passing the dipeptide through a silica column, 0.55 g
(0.8 mmol, 47%) of the pure compound was obtained. Fmoc-Val-
Cys(Ψpmppro)-OH (137 mg, 0.24 mmol) was dissolved in DCM (10
mL) at -10 °C before adding NMM (49 mg, 0.48 mmol) and
isobutylchloroformate (35 mg, 0.26 mmol), and stirring continued for
5 min. Phe-pNA (72 mg, 0.25 mmol, 1.05 equiv) in DCM (1 mL)
was added, and the reaction mixture was allowed to slowly warm to
roomtemperature. Without further workup, Fmoc-deprotection was
carried out by the addition of DBU (105 µL, 2.75 equiv, 15 min). All
liquid was evaporated, and the remaining yellow oil diluted in few
acetonitrile/water (2 mL, 1:1 v/v). The desired compound NH2-Val-
Cys(Ψpmppro)-Phe-pNA obtained as an epimeric mixture after purifica-
tion on a HPLC preparative (C18), using a gradient of 5-100% B within
30 min. Treating the epimers with succinic anhydride (40 mg, 2 equiv)
in the presence of NMM (40 µL) in DCM (5 mL) gave Suc-Val-Cys-
(Ψpmppro)-Phe-pNA 2S and 2R. Separation of the stereoisomers was
carried out by means of HPLC preparative using a gradient 55-65%
B in 30 min (C18). (S)-epimer (10%): Yield 24 mg (14%). HPLC
analytic: tR ) 11.33 min (60-100% B, 40 min). HPLC analytic: (R)-
One hundrend milligrams of the above-described substance was
dissolved with DMF (3 mL) before adding succinic anhydride (2 equiv,
42 mg) and NMM (2 equiv, 42 mg) and stirring for 12 h. The desired
product, tR ) 9.59 min (60-100% B, 40 min, C18, 68% purity) was
separated from the impurities and secondary products by means of a
C18 Sep-Pak column (isocratic, 30% A, 70% B) to give Suc-Val-
Ser(ΨH,Hpro)-Phe-pNA 5 with 88% purity (HPLC analytic). Purifica-
tion to a single peak on HPLC analytic was done on a preparative HPLC
(C18, isocratic, 35% A, 65% B). Overall yield 60 mg (0.1 mmol, 13%).
1H NMR (400 MHz, 303 K, DMSO-d6, 10 mg/mL) 10.6 (s, 1H, NH-